Triple Helix Discovery Engine
Triple Helix Framework
Industry
Architects: Small & Medium Size Business (SMBs), Product Development, De-Risking, Validation, Building Niche & Emerging Markets
*Architects: Neurology, Psychology, Mental Health, CNS, Pain & TBI Companies_Pain
NeuroMetrix Inc. (NASDAQ:NURO)*

Organization & Developments: NeuroMetrix

Parents

2011: Diabetes blood test boosted by NeuroMetrix, Nipro pact (2011)
2011: NeuroMetrix disbands direct sales, lays off 27 percent of workers (2011)
2011: NeuroMetrix said it plans to dissolve its direct sales operations, lay off 27% of its staff and stop the development of its NC-stat neurodiagnostic device to focus its resources on the development of its Advance system that would cater to patients with Typ
2021: NeuroMetrix: Solving Unmet Needs In Diagnostics And Therapeutic Neurostimulation
2022: NeuroMetrix Receives FDA Breakthrough Device Designation for Treatment of Chronic Chemotherapy Induced Peripheral Neuropathy (CIPN) with its Wearable Neurostimulation Technology_globenewswire
2022: NeuroMetrix: Strong Unit Economics, Accelerating Growth; Possibly Worth $15 In 5 Years_seekingalpha.com
2023: NeuroMetrix on pins and needles as it launches revamped peripheral neuropathy test
Engaged in the designing, building and marketing of medical devices that stimulate nerves and analyze nerve response for diagnostic and therapeutic purposes.
It has two principal product categories, which includes point-of-care neuropathy diagnostic tests and wearable neurostimulation devices.
QUELL-FM